Literature DB >> 33804536

Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?

Ersilia Nigro1,2, Fabio Perrotta3, Filippo Scialò2,4, Vito D'Agnano3, Marta Mallardo1,2, Andrea Bianco2,4, Aurora Daniele1,2.   

Abstract

Lung cancer still represents the leading cause of cancer-related death, globally. Likewise, malnutrition and inactivity represent a major risk for loss of functional pulmonary capacities influencing overall lung cancer severity. Therefore, the adhesion to an appropriate health lifestyle is crucial in the management of lung cancer patients despite the subtype of cancer. This review aims to summarize the available knowledge about dietary approaches as well as physical activity as the major factors that decrease the risk towards lung cancer, and improve the response to therapies. We discuss the most significant dietary schemes positively associated to body composition and prognosis of lung cancer and the main molecular processes regulated by specific diet schemes, functional foods and physical activity, i.e., inflammation and oxidative stress. Finally, we report evidence demonstrating that dysbiosis of lung and/or gut microbiome, as well as their interconnection (the gut-lung axis), are strictly related to dietary patterns and regular physical activity playing a key role in lung cancer formation and progression, opening to the avenue of modulating the microbiome as coadjuvant therapy. Altogether, the evidence reported in this review highlights the necessity to consider non-pharmacological interventions (nutrition and physical activity) as effective adjunctive strategies in the management of lung cancer.

Entities:  

Keywords:  lung cancer; microbiota; nutrition; physical activity; sarcopenia

Year:  2021        PMID: 33804536      PMCID: PMC7967729          DOI: 10.3390/ijerph18052399

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  173 in total

Review 1.  Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application.

Authors:  Brett C Bade; D David Thomas; JoAnn B Scott; Gerard A Silvestri
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

2.  Diet, cancer, and NCD prevention.

Authors:  Michael Marmot
Journal:  Lancet Oncol       Date:  2018-05-24       Impact factor: 41.316

3.  Adherence to Dietary Approaches to Stop Hypertension (DASH)-Style Diet and the Risk of Cancer: A Systematic Review and Meta-Analysis of Cohort Studies.

Authors:  Mohammad Ali Mohsenpour; Roohallah Fallah-Moshkani; Reza Ghiasvand; Hossein Khosravi-Boroujeni; Seyed Mehdi Ahmadi; Paula Brauer; Amin Salehi-Abargouei
Journal:  J Am Coll Nutr       Date:  2019-05-29       Impact factor: 3.169

4.  Exercise in patients with non-small cell lung cancer.

Authors:  Lea Kuehr; Joachim Wiskemann; Ulrich Abel; Cornelia M Ulrich; Simone Hummler; Michael Thomas
Journal:  Med Sci Sports Exerc       Date:  2014-04       Impact factor: 5.411

5.  Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.

Authors:  H Y Chen; M E Trumbauer; A S Chen; D T Weingarth; J R Adams; E G Frazier; Z Shen; D J Marsh; S D Feighner; X-M Guan; Z Ye; R P Nargund; R G Smith; L H T Van der Ploeg; A D Howard; D J MacNeil; S Qian
Journal:  Endocrinology       Date:  2004-02-12       Impact factor: 4.736

Review 6.  The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.

Authors:  Rishi Jain; Chris Coss; Peter Whooley; Mitch Phelps; Dwight H Owen
Journal:  Curr Oncol Rep       Date:  2020-05-15       Impact factor: 5.075

7.  Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model.

Authors:  Laure B Bindels; Raphaël Beck; Olivier Schakman; Jennifer C Martin; Fabienne De Backer; Florence M Sohet; Evelyne M Dewulf; Barbara D Pachikian; Audrey M Neyrinck; Jean-Paul Thissen; Julien Verrax; Pedro Buc Calderon; Bruno Pot; Corinne Grangette; Patrice D Cani; Karen P Scott; Nathalie M Delzenne
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

Review 8.  Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited).

Authors:  Priyanka Patel; Doraid Alrifai; Fiona McDonald; Martin Forster
Journal:  Br J Cancer       Date:  2020-12       Impact factor: 7.640

9.  Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.

Authors:  Yuki Enoki; Hiroshi Watanabe; Riho Arake; Ryusei Sugimoto; Tadashi Imafuku; Yuna Tominaga; Yu Ishima; Shunsuke Kotani; Makoto Nakajima; Motoko Tanaka; Kazutaka Matsushita; Masafumi Fukagawa; Masaki Otagiri; Toru Maruyama
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.